What partners we are looking for

SimuGen is working with a number of established partner companies and continues to look for further development and marketing partnerships. It is the company’s vision to continue expanding partnerships along three paths:

• Integration into early-stage ADMET screening labs
• Application to different cell culture models for multiple target organ toxicities
• Addressing drug withdrawals from the market due to safety problems

If you are an ADMET screening lab we would be keen to talk to you and discuss how we can integrate SimuGen's products and services in your workflows, which will give you a clear competitive edge in your predictive toxicology screening capabilities. Please contact us if your lab is interested to use SimuGen's HT-Stream software and/or become a service partner for our HT-X drug safety screening programmes. 

Investors

SimuGen is funded by Venture Capital firm Modal Perdana and a group of Business Angels based in the UK and Malaysia. In addition, the company received grant funding from the Malaysian Biotechnology Corporation.